Why the study?
To explore coronary CTA-based classifications for predicting MACE risk in patients with suspected non-obstructive CAD compared with traditional NOCAD, Duke prognostic NOCAD index, and NOCAD-RADS.
Does the coronary CTA-based stenosis proximal involvement (SPI) classification predict MACE in patients with suspected non-obstructive CAD?
Does the coronary CTA-based stenosis proximal involvement (SPI) classification predict MACE in patients with suspected non-obstructive CAD?
A novel coronary CTA-based classification incorporating plaque location (stenosis proximal involvement) provides prognostic value for MACE in non-obstructive CAD that is non-inferior to traditional scoring systems.
May refine MACE stratification in non-obstructive CAD beyond NOCAD-RADS; hypothesis-generating, requires prospective validation before clinical adoption.
We aim to explore the classifications based on coronary computed tomography angiography (CTA) for predicting the risk of major adverse cardiovascular events (MACE) in patients with suspected non-obstructive coronary artery disease (CAD) and compare with traditional non-obstructive CAD (NOCAD) classification, Duke prognostic NOCAD index, Non-obstructive coronary artery disease reporting and data system (NOCAD-RADS). 4378 consecutive non-obstructive CAD patients were assessed by coronary CTA for traditional NOCAD classification, Duke prognostic NOCAD index, NOCAD-RADS and a new classification (stenosis proximal involvement, SPI) from two medical centrals. We defined proximal involvement as any plaque was present in the main or proximal segments of coronary artery (left main, left anterior descending artery, left circumflex artery, or right coronary artery). The main outcome was MACE. During a median follow-up of 3.7 years, a total of 310 patients experienced MACE event. Kaplan-Meier survival curves showed the cumulative events increased significantly associated with traditional NOCAD, Duke NOCAD index, NOCAD-RADS and SPI classifications (all P < 0.001). In multivariate Cox regressions, the risk for the events increased from HR 1.20 (95% CI 0.78-1.83, P = 0.408) for SPI 1 to 1.35 (95% CI 1.05-1.73, P = 0.019) for SPI 2, using SPI 0 as the reference group. Coronary CTA based SPI classification provided important prognostic information for all cause-mortality risk and MACE prediction in patients with non-obstructive CAD, which was non-inferior than traditional NOCAD, Duke NOCAD Index and NOCAD-RADS classifications. The plaque location information by coronary CTA may provide additional risk prediction in patients with non-obstructive CAD.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: